|Day's Range||82.13 - 85.33|
|52 Week Range||31.38 - 86.92|
|PE Ratio (TTM)||-17.64|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Shares of Alnylam Pharmaceuticals, Inc. (ALNY) soared 93.3% this year so far massively outperforming the 2.6% increase registered by the Zacks classified Biomed/Genetics industry during this period.
Alnylam (ALNY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
During the week ended May 26, 2017, Alexion Pharmaceuticals (ALXN) saw the biggest loss in the healthcare sector. ALXN's stock price witnessed a steep fall of ~14.2%.